English

This guide provides a summary of safety and efficacy data for drugs currently in use to treat TB. The guide also suggests advocacy points for activists, clinicians, and others working in TB.

This guide was developed by the Global Laboratory Initiative, which is one of the Working Groups of the Stop TB Partnership. The guide replaces both the 1998 WHO and 2000 IUATLD guides on smear microscopy and contains many new elements.

This online course explains how the FAST strategy can be applied in various settings. FAST stands for: Finding TB cases, Actively, Separating safely, and Treating effectively.

This online course discusses critical principles and steps to facilitate treatment adherence for MDR-TB patients. The five A’s are: Assess, Advise, Agree, Arrange, and Assist.

This pocket guide is intended to be a resource for physicians and other health care professionals who provide care and treatment to patients with MDR TB. The guide is a revision of The PIH Guide to the Medical Management of MDR-TB that was published in 2003.

This laboratory manual references best practices from the Clinical and Laboratory Standards Institute (CLSI), the Foundation for Innovative New Diagnostics (FIND) MGIT Procedure Manual, and laboratory procedures from the National Institutes of Health TB Research Unit, as well as biosafety recommendations from the World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC).

Information in the manual includes standardized procedures related to sputum collection, handling, analyses, and reporting.

The TB Voices Project documented individuals' TB experience using photos, video/voice recordings, and/or their written story. Twenty-eight people from across King and Snohomish County, Washington shared their TB experiences through the TB Voices Project in 2013. The website contains: video and audio clips of more than 25 TB stories; a 13 minute video applicable for all audiences; and an active blog.

This guide specifically addresses issues such as stigma and work discrimination, and also provides practical recommendations on how to establish an effective monitoring system.

This document includes recommendations for improving the management of children with TB and of children living in families with TB. National and regional TB control programmes may wish to adapt these recommendations according to local circumstances.

This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.